Phil Smith Neuroscience Institute at Holy Cross Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2019
NCT03883581
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Phil Smith Neuroscience Institute at Holy Cross Hospital